Abstract
N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors with a key role in behavioral and cognitive processes. Disruption of NMDARs has traditionally been linked to several neurological disorders, including schizophrenia. NMDAR antagonists can be used as experimental models of symptoms associated with the neural disorders caused by NMDAR dysfunctions, as well as in preclinical studies, to evaluate the effectiveness of potential antipsychotic drugs or cognitive enhancers. The effects of low doses (0.05, 0.1, and 0.2 mg/kg) of MK-801 (a noncompetitive NMDAR antagonist) on motor and cognitive functions were assessed in adult mice. The three doses increased motor activities and evoked inverted-U prepulse inhibition changes, but only the two higher doses impaired associative learning, therefore allowing its application in preclinical studies of cognitive-related deficits. In addition, this study was aimed at determining the motor and behavioral effects produced by subanesthetic doses of ketamine (a non-specific NMDA antagonist) in adult mice and the possibility of generating a mild cognitive impairment model for pharmacological purposes. We evaluated how low doses (10, 15, and 20 mg/kg) of ketamine affected the acquisition of an instrumental conditioning task, as well as their effects on motor and prepulse inhibition capabilities. Results of ketamine administration indicate a clear dose-dependent decrease of learning abilities and motor and prepulse inhibitory effects at the highest dose. Thus, ketamine administration at these three doses can be used as a model of cognitive impairment and for the induction of schizophrenic symptoms. The use of these two drugs at low doses in experimental models of selected cognitive disorders is discussed.
Marta Lovera-Ulecía and Lucía Moreno-Lama have contributed equally with all other contributors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zhou, H.X., Wollmuth, L.P.: Advancing NMDA receptor physiology by integrating multiple approaches. Trends Neurosci. 40, 129–137 (2017)
Wiescholleck, V., Manahan-Vaughan, D.: Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis. Neuropharmacology. 74, 48–58 (2013)
Vanderschuren, L.J., Schoffelmeer, A.N., Mulder, A.H., De Vries, T.J.: Dizocilpine (MK801): use or abuse? Trends Pharmacol. Sci. 19, 79–81 (1998)
Fix, A.S., Horn, J.W., Wightman, K.A., Johnson, C.A., Long, G.G., Storts, R.W., Olney, J.W.: Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK (+) 801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 123, 204–215 (1993)
Collingridge, G.L., Volianskis, A., Bannister, N., France, G., Hanna, L., Mercier, M., Tidball, P., Fang, G., Irvine, M.W., Costa, B.M., Monaghan, D.T., Bortolotto, Z.A., Molnár, E., Lodge, D., Jane, D.E.: The NMDA receptor as a target for cognitive enhancement. Neuropharmacology. 64, 13–26 (2013)
Miyamoto, S., Leipzig, J.N., Lieberman, J.A., Duncan, G.E.: Effects of Ketamine, MK-801, and amphetamine on regional brain 2-Deoxyglucose uptake in freely moving mice. Neuropsycopharmacology. 22, 400–412 (2000)
Mion, G., Villevieille, T.: Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci. Ther. 19, 370–380 (2013)
Domino, E., Chodoff, P., Corssen, G.: Pharmacologic effects of CI-581, a new dissociative anaesthetic in human. Clin. Pharmacol. Ther. 6, 279–291 (1965)
Borrell, J., Vela, J.M., Arévalo-Martin, A., Molina-Holgado, E., Guaza, C.: Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology. 26, 204–215 (2002)
Porras-García, E., Cendelin, J., Domínguez-del-Toro, E., Vožeh, F., Delgado-García, J.M.: Purkinje cell loss affects differentially the execution, acquisition and prepulse inhibition of skeletal and facial motor responses in Lurcher mice. Eur. J. Neurosci. 21, 979–988 (2005)
Eleore, L., López-Ramos, J.C., Yi, P.J., Delgado-García, J.M.: The cognitive enhancer T-588 partially compensates the motor associative learning impairments induced by scopolamine injection in mice. Behav. Neurosci. 121, 1203–1214 (2007)
Jurado-Parras, M.T., Gruart, A., Delgado-García, J.M.: Observational learning in mice can be prevented by medial prefrontal cortex stimulation and enhanced by nucleus accumbens stimulation. Learn. Mem. 19, 99–106 (2012)
Jurado-Parras, M.T., Delgado-García, J.M., Sánchez-Campusano, R., Gassmann, M., Bettler, B., Gruart, A.: Presynaptic GABAB receptors regulate hippocampal synapses during associative learning in behaving mice. PLoS One. 11, e0148800 (2016)
Madroñal, N., López-Aracil, C., Rangel, A., del Río, J.A., Delgado-García, J.M., Gruart, A.: Effect of enriched physical and social environments on motor performance, associative learning, and hippocampal neurogenesis in mice. PLoS One. 5, e11130 (2010)
Liljequist, S., Ossowska, K., Grabowska-Anden, M., Anden, N.E.: Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur. J. Pharmacol. 195, 55–61 (1991)
Yee, B.K., Chang, D.T., Feldon, J.: The effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice. Neuropsychopharmacology. 29, 1865–1877 (2004)
Chatterjee, M., Ganguly, S., Srivastava, M., Palit, G.: Effect of ‘chronic’ versus ‘acute’ ketamine administration and its ‘withdrawal’ effect on behavioural alterations in mice: implications for experimental psychosis. Behav. Brain Res. 216, 247–254 (2011)
Cilia, J., Hatcher, P., Reavill, C., Jones, D.N.: Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics. J. Psychopharmacol. 2, 302–311 (2007)
Hsu, H.-R., Mei, Y.-Y., Wu, C.-Y., Chiu, P.-H., Chen, H.-H.: Behavioural and toxic interaction profile of ketamine in combination with caffeine. J. Compil. Basic Clin. Pharmacol. Toxicol. 104, 379–383 (2009)
Pallarés, M.A., Nadal, R.A., Silvestre, J.S., Ferré, N.S.: Effects of ketamine, a noncompetitive NMDA antagonist, on the acquisition of the lever-press response in rats. Physiol. Behav. 57, 389–392 (1995)
Acknowledgments
We thank Ms. Olga Palomo-Casillas, Ms. María Sánchez-Enciso, and Mr. José M. González-Martin for their collaboration in animal experiments and data analysis. We also thank Mr. Roger Churchill for his editorial help.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Lovera-Ulecía, M., Moreno-Lama, L., Gómez-Climent, M.Á., Delgado-García, J.M., Gruart, A. (2018). Behavioral and Cognitive Impairments Induced by Low Doses of MK-801 and Ketamine. In: Delgado-García, J., Pan, X., Sánchez-Campusano, R., Wang, R. (eds) Advances in Cognitive Neurodynamics (VI). Advances in Cognitive Neurodynamics. Springer, Singapore. https://doi.org/10.1007/978-981-10-8854-4_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-8854-4_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8853-7
Online ISBN: 978-981-10-8854-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)